CIK: 1591313 - Address: C/O Xencor, Inc., 465 N Halstead Street, Suite 200, Pasadena, CA 91107
30 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret117-2-1-263010723
S%wins717171500044

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/12/24 16:05
3/11/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS-3023.500-1-1186D
3/7/24 16:05
3/5/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS.d-15523.430-7-3188D
2/16/24 16:06
2/14/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOM.d13211.050127174D
2/14/24 14:23
2/13/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOM.d75211.0506873162D
2/14/24 14:23
2/13/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS.d-1,04919.380-54-25162D
3/13/23 19:42
3/9/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS-3729.880-1-1148D
3/8/23 19:58
3/6/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS-13231.420-4-3149D
3/6/23 21:05
3/3/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS.d-3931.540-1-1154D
3/10/22 17:00
3/9/22
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS-3429.130-1-1136D
3/7/22 17:00
3/3/22
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS.d-3729.860-1-1137D
3/3/21 20:01
3/3/21
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,CSOS-5245.030-1-192D
9/10/19 18:12
9/6/19
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.d1174.250284984D
8/21/19 16:21
8/19/19
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS-1,42440.690-35-3856D
8/10/18 18:36
8/9/18
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.d1494.250356688D
8/10/18 18:36
8/9/18
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS.dm-1,41340.360-35-2888D
3/17/17 18:31
3/15/17
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS-33724.476-14-1488D561083-6-25-2-11-2-7
12/7/16 16:30
12/5/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.d690.590010118101D1649997343464151-5-4-8
12/7/16 16:30
12/5/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS.d-1,19626.5710-45-31101D1649997343464151-5-4-8
8/24/16 20:54
8/23/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS-35421.736-16-3629D111309363192-30-2218257
8/5/16 16:59
8/3/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS-11820.005-6-1245D113-21049149171811-4-3-10-99
8/5/16 16:57
3/2/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS.am-16712.015-14-2251D113-21049149171811-4-3-10-99
8/5/16 16:57
3/3/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.a40.5900571651D113-21049149171811-4-3-10-99
3/3/16 21:26
3/2/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.dm210.590033624050D5-26-29-26-2836-210182285121
3/3/16 21:26
3/2/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS.dm-17112.013-14-2250D5-26-29-26-2836-210182285121
1/15/16 19:00
1/14/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.d10.590062629D41-27-4811-23-17-67-6-2-81747108
1/6/16 20:09
1/4/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.d10.590071427D48-15-401-4-1-12-5-5-7-20134293
1/6/16 20:09
1/4/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseS.d-1614.137-1-427D48-15-401-4-1-12-5-5-7-20134293
2/2/15 20:26
1/30/15
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOSVP,ReseM.d160.5900426999%28D695744-3-12-12-11-6-25-447-28
4/22/14 16:41
12/19/13
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOVP,ReseaM.ad00.590030999%0D4-22-14-17-1-4-23-4-144
12/20/13 16:24
12/19/13
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDesjarlais John RCAOVP,ReseaM.d00.590020999%0D-4-2160293092

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact